Egyptian Drug Authority signs cooperation protocol to enhance training in the medical sector
The activities of the fifth edition of the Africa Health ExCon 2026 witnessed a new step aimed at developing the health sector in Egypt. The Egyptian Drug Authority signed a joint cooperation protocol with GlaxoSmithKline Egypt, as part of the state's ongoing efforts to support the pharmaceutical industries.
This protocol primarily aims to enhance training and professional development programs for workers in the pharmaceutical sector. Through this partnership, the Authority seeks to raise the efficiency of human resources and develop scientific and practical skills in line with the latest international standards in the pharmaceutical industry.
This initiative is part of the Egyptian Drug Authority's strategy to strengthen cooperation with international and local companies. This collaboration is expected to contribute to improving the quality of services provided to citizens and ensuring the availability of medicines that meet the highest technical and regulatory specifications.
This event underscores the importance of the Africa Health ExCon as a regional platform that brings together experts and decision-makers in the medical field. Egypt continues to host these events to strengthen its position as a regional hub for medical and pharmaceutical industries on the African continent.
In conclusion, this step reflects the Authority's commitment to developing the healthcare system in Egypt by investing in human capital and localizing modern technology, which will positively reflect on the health of the Egyptian citizen and the availability of pharmaceutical products in the markets.